Dermtech Stock Buy Hold or Sell Recommendation
| DMTK Stock | USD 0.61 0.01 0.97% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding DermTech is 'Strong Sell'. Macroaxis provides DermTech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DermTech positions. The advice algorithm takes into account all of DermTech's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting DermTech's buy or sell advice are summarized below:
Real Value 0.6 | Target Price 5.1 | Hype Value 0.62 | Market Value 0.61 | Naive Value 0.45 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell DermTech given historical horizon and risk tolerance towards DermTech. When Macroaxis issues a 'buy' or 'sell' recommendation for DermTech, the advice is generated through an automated system that utilizes algorithms and statistical models.
DermTech |
Execute DermTech Buy or Sell Advice
The DermTech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on DermTech. Macroaxis does not own or have any residual interests in DermTech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute DermTech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
DermTech Trading Alerts and Improvement Suggestions
| DermTech generated a negative expected return over the last 90 days | |
| DermTech has high historical volatility and very poor performance | |
| DermTech has some characteristics of a very speculative penny stock | |
| DermTech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 15.3 M. Net Loss for the year was (100.89 M) with profit before overhead, payroll, taxes, and interest of 647 K. | |
| DermTech currently holds about 173.79 M in cash with (76.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from seekingalpha.com: DermTech exploring strategic alternatives, cutting 56 percent of staff |
DermTech Returns Distribution Density
The distribution of DermTech's historical returns is an attempt to chart the uncertainty of DermTech's future price movements. The chart of the probability distribution of DermTech daily returns describes the distribution of returns around its average expected value. We use DermTech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of DermTech returns is essential to provide solid investment advice for DermTech.
| Mean Return | -0.9 | Value At Risk | -6.25 | Potential Upside | 4.84 | Standard Deviation | 5.56 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of DermTech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
DermTech Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DermTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DermTech backward and forwards among themselves. DermTech's institutional investor refers to the entity that pools money to purchase DermTech's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Susquehanna International Group, Llp | 2023-12-31 | 85.7 K | Woodmont Investment Counsel Llc | 2023-12-31 | 84.2 K | Northern Trust Corp | 2023-12-31 | 77.5 K | Bank Of New York Mellon Corp | 2023-12-31 | 75.2 K | Jane Street Group, Llc | 2023-12-31 | 74.8 K | State Treasurer State Of Michigan | 2023-12-31 | 60 K | Advisor Group Holdings, Inc. | 2023-12-31 | 59.3 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 57.6 K | Virtu Financial Llc | 2023-12-31 | 55.2 K | Vanguard Group Inc | 2023-12-31 | 1.4 M | Blackrock Inc | 2023-12-31 | 434.9 K |
DermTech Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 5K | (69K) | (376K) | (1.3M) | 753K | 790.7K | |
| Change In Cash | 10.6M | 8.9M | 155.7M | (98.7M) | (41.0M) | (39.0M) | |
| Net Borrowings | 2.1M | (9K) | (171K) | (137K) | (123.3K) | (117.1K) | |
| Depreciation | 89K | 486K | 2.3M | 4.5M | 5.8M | 6.1M | |
| Capital Expenditures | 210K | 1.8M | 2.7M | 3.3M | 902K | 913.0K | |
| Net Income | (19.7M) | (35.2M) | (78.3M) | (116.7M) | (100.9M) | (95.8M) | |
| Change To Netincome | (838K) | 5.0M | 14.4M | 19.1M | 22.0M | 23.1M | |
| End Period Cash Flow | 15.4M | 24.2M | 179.9M | 81.2M | 36.7M | 41.3M | |
| Free Cash Flow | (18.0M) | (30.5M) | (64.8M) | (98.6M) | (77.9M) | (74.0M) | |
| Other Non Cash Items | 414K | (21K) | 1.9M | 585K | 29.3M | 30.7M |
DermTech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DermTech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DermTech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a DermTech stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -1.05 | |
β | Beta against NYSE Composite | 1.66 | |
σ | Overall volatility | 5.65 | |
Ir | Information ratio | -0.18 |
DermTech Volatility Alert
DermTech exhibits very low volatility with skewness of -2.64 and kurtosis of 14.24. DermTech is a potential penny stock. Although DermTech may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in DermTech. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on DermTech instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.DermTech Fundamentals Vs Peers
Comparing DermTech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze DermTech's direct or indirect competition across all of the common fundamentals between DermTech and the related equities. This way, we can detect undervalued stocks with similar characteristics as DermTech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of DermTech's fundamental indicators could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare DermTech to competition |
| Fundamentals | DermTech | Peer Average |
| Return On Equity | -1.06 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Operating Margin | (5.03) % | (5.51) % |
| Current Valuation | 19.86 M | 16.62 B |
| Shares Outstanding | 34.62 M | 571.82 M |
| Shares Owned By Insiders | 4.24 % | 10.09 % |
| Shares Owned By Institutions | 21.08 % | 39.21 % |
| Number Of Shares Shorted | 3.16 M | 4.71 M |
| Price To Earning | (139.70) X | 28.72 X |
| Price To Book | 0.38 X | 9.51 X |
| Price To Sales | 1.41 X | 11.42 X |
| Revenue | 15.3 M | 9.43 B |
| Gross Profit | 647 K | 27.38 B |
| EBITDA | (97.89 M) | 3.9 B |
| Net Income | (100.89 M) | 570.98 M |
| Cash And Equivalents | 173.79 M | 2.7 B |
| Cash Per Share | 5.78 X | 5.01 X |
| Total Debt | 54.39 M | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 12.19 X | 2.16 X |
| Book Value Per Share | 1.66 X | 1.93 K |
| Cash Flow From Operations | (76.98 M) | 971.22 M |
| Short Ratio | 6.32 X | 4.00 X |
| Earnings Per Share | (3.09) X | 3.12 X |
| Target Price | 2.04 | |
| Number Of Employees | 206 | 18.84 K |
| Beta | 2.56 | -0.15 |
| Market Capitalization | 21.33 M | 19.03 B |
| Total Asset | 121.93 M | 29.47 B |
| Retained Earnings | (423.94 M) | 9.33 B |
| Working Capital | 48.3 M | 1.48 B |
| Current Asset | 140.61 K | 9.34 B |
| Current Liabilities | 446.54 K | 7.9 B |
Note: Acquisition by Todd Wood of 85114 shares of DermTech subject to Rule 16b-3 [view details]
DermTech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as DermTech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About DermTech Buy or Sell Advice
When is the right time to buy or sell DermTech? Buying financial instruments such as DermTech Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Cash | 176.9M | 77.8M | 36.7M | 33.4M | Accounts Payable | 2.9M | 2.4M | 1.5M | 1.2M |
Use Investing Ideas to Build Portfolios
In addition to having DermTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out DermTech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.